12/17
03:07 pm
cbll
CeriBell (NASDAQ:CBLL) had its price target raised by analysts at Canaccord Genuity Group Inc. from $29.00 to $30.00. They now have a "buy" rating on the stock.
Low
Report
CeriBell (NASDAQ:CBLL) had its price target raised by analysts at Canaccord Genuity Group Inc. from $29.00 to $30.00. They now have a "buy" rating on the stock.
12/15
07:20 am
cbll
CeriBell (NASDAQ:CBLL) had its "buy" rating reaffirmed by analysts at BTIG Research.
Medium
Report
CeriBell (NASDAQ:CBLL) had its "buy" rating reaffirmed by analysts at BTIG Research.
12/12
09:49 am
cbll
AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs
Low
Report
AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs
12/9
12:17 pm
cbll
CeriBell (NASDAQ:CBLL) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Medium
Report
CeriBell (NASDAQ:CBLL) had its "buy" rating reaffirmed by analysts at Cowen Inc.
12/9
08:00 am
cbll
Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution
Low
Report
Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution
11/24
08:00 am
cbll
Ceribell Receives FDA 510(k) Clearance for Use of Clarity? Algorithm for Neonates
Medium
Report
Ceribell Receives FDA 510(k) Clearance for Use of Clarity? Algorithm for Neonates
11/19
04:05 pm
cbll
Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference
Low
Report
Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference
11/6
04:05 pm
cbll
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Medium
Report
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
11/5
03:01 pm
cbll
CeriBell (NASDAQ:CBLL) had its price target lowered by analysts at JPMorgan Chase & Co. from $21.00 to $17.00. They now have an "overweight" rating on the stock.
Low
Report
CeriBell (NASDAQ:CBLL) had its price target lowered by analysts at JPMorgan Chase & Co. from $21.00 to $17.00. They now have an "overweight" rating on the stock.
11/5
02:21 pm
cbll
CeriBell (NASDAQ:CBLL) had its price target lowered by analysts at TD Cowen from $36.00 to $20.00. They now have a "buy" rating on the stock.
Low
Report
CeriBell (NASDAQ:CBLL) had its price target lowered by analysts at TD Cowen from $36.00 to $20.00. They now have a "buy" rating on the stock.
11/4
04:05 pm
cbll
Ceribell Reports Third Quarter 2025 Financial Results
Medium
Report
Ceribell Reports Third Quarter 2025 Financial Results
10/21
04:05 pm
cbll
Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025
Low
Report
Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025
10/21
08:03 am
cbll
CeriBell (NASDAQ:CBLL) is now covered by analysts at Raymond James Financial, Inc.. They set a "strong-buy" rating and a $19.00 price target on the stock.
Medium
Report
CeriBell (NASDAQ:CBLL) is now covered by analysts at Raymond James Financial, Inc.. They set a "strong-buy" rating and a $19.00 price target on the stock.